Fauci, wat Woensdag deelgeneem het aan die COVID-19 White House-inligtingsessie wat ure voor die CDC se advieskomitee vir immuniseringspraktyke gehou is (ACIP) is ingestel om te vergader rakende die een-dosis jab se veiligheidsdata, also mentioned that work has already begun on the ground to address hesitancy with a Zoom call involving 2,000 community leaders Tuesday night.
“The fact that following the EUA, we have continued to follow very carefully any possibility of adverse events, Ek glo, is the other side of the coin of hesitancy,” Fauci gesê. “It should reinforce in those individuals how we take safety so seriously, so as opposed to looking at this as a negative safety issue, it could be looked at as a positive issue, where they know that when we let a vaccine be available and give it a go-ahead to be put into the arms of the American people, we do it with a considerable degree of confidence as to its safety. So when I get asked questions about whether or not this has set us back, from a hesitancy standpoint, I give the opposite of that.”
White House COVID-19 Response Coordinator Jeff Zients also added federal officials are working with state partners to help reschedule and shift appointments for Americans who were slated to receive the Johnson & Johnson product. He again repeated that the U.S. het “more than enough supply” to keep up with its current pace of administering around 3 million doses per day.
“Soos jy weet, yesterday the FDA and CDC announced that out of an abundance of caution they have recommended a pause in the use of the Johnson & Johnson vaccine as they review data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine,” Zients said. “I want to be clear that this announcement will not have a significant impact on our vaccination program. The J&J vaccine makes up less than 5% of the more than 190 million reported shots in arms in the U.S. to date.”
Zients said that 28 million doses of the Pfizer- BioNTech and Moderna vaccines are being shipped out this week. He added that President Biden’s initiative to move up production and delivery schedules for Pfizer-BioNTech and Moderna has also ensured that the country will secure enough doses for more than 300 million Americans by the end of July.